Podcasts about antibiotic resistance

Matters Microbial #89: Can AI Point Us to New Antibiotics May 1, 2025 Today, Dr. Amir Mitchell, Associate Professor of Systems Biology at the University of Massachusetts Medical School, joins the #QualityQuorum to discuss using artificial intelligence to develop new and effective antibiotics in our endless battle against drug-resistant microbes. Host: Mark O. Martin Guest: Amir MItchell Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode An article exploring the impact of the microbiome on drug effectiveness. A blog post discussing the relationship between the gut microbiome and creosote metabolism in wood rats. An essay about the threat of antibiotic resistance. A more scholarly article on this topic. A CDC report of the rise of antibiotic resistance. A very moving TED talk on this topic. An overview of antibiotic resistance mechanisms. A video from Dr. Michael Baym's laboratory demonstrating how rapidly antibiotic resistance can occur. An essay discussing the use of artificial intelligence in the search for new antibiotics.  An article from Dr. Mitchell's research group discussing his approach to identity new antimicrobial compounds. Dr. Mitchell's faculty website. Dr. Mitchell's very interesting research team website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Phage therapy is stepping into the spotlight as antibiotic resistance rises - and Jessica Sacher is helping lead the charge. In this episode, Ross Katz speaks with Jessica, Co-Founder of Phage Directory and Staff Scientist at Stanford, about sourcing phages, operationalizing therapy, and predicting efficacy through data. This conversation explores how personalized phage therapy works, its scalability, and the data challenges shaping its future. ​​What You'll Learn in This Episode: Why phage therapy is a promising solution to antibiotic-resistant infectionsHow Phage Directory connects researchers and clinicians to accelerate treatmentWhat operational hurdles exist in scaling personalized phage productionHow data science is being applied to predict effective phage-bacteria matchesWhy building infrastructure and awareness is essential to adoption in clinical care Connect with Our Guest: Sponsor: CorrDyn, a data consultancyFind out more about Phage DirectoryConnect with Jessica on LinkedIn Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode! Resources Mentioned:  Why Language Itself Might Be Holding Back AI – by Ross Katz: https://www.linkedin.com/pulse/why-language-itself-might-holding-back-ai-ross-katz-rcl9e/?trackingId=Y6%2FH45W%2BxImfl%2By2geB6%2Bg%3D%3DBacteriophage Therapy for Multidrug-Resistant Infections – PubMed: https://pubmed.ncbi.nlm.nih.gov/40026251/Cystic Fibrosis Australia and Phage Australia Survey – medRxiv: https://www.medrxiv.org/content/10.1101/2024.05.14.24307275v1Phage Directory: https://phage.directory/

Do you keep relapsing after treating candida, SIBO or other conditions? The culprit behind these never-ending cycles may be biofilms. In this episode, I'll explain how biofilms form, help you identify signs that you have them, and recommend the best antibiofilm agents. Tune in!   Learn more about biofilms and improve your gut now! Reach out to our virtual clinic: https://drruscio.com/virtual-clinic/  

Microplastics are a real problem.  They are pretty much everywhere.  They are in our food, in the oceans, on mountains, up in the clouds, and most alarmingly, in our bodies.  All of that is already bad news, but researchers at Boston University have found that microplastics may also be contributing to antibiotic resistance in dangerous […]

Doctors here say New Zealand's high use of antibiotic medication, among the top five in the world per capita, has put us at risk. The World Health Organisation considers antimicrobial resistance as one of the top global public health threats in the 21st century. But as Victor Waters explains, a kiwi tech company is doing it's bit to prepare medical defences

This episode discusses the growing threat of sepsis, a life-threatening condition caused by the body's overwhelming response to an infection. It explores the connection between the rise in sepsis cases and the increasing problem of antibiotic resistance, highlighting the importance of effective diagnostic tools and antibiotic stewardship programs in combating this public health challenge.   About Our Speaker: Dr. Mike Broyles With more than 30 years of experience as a hospital pharmacy and laboratory director, Dr. Broyles is a leading expert on sepsis and the clinical use of drugs with a focus on antimicrobial stewardship. Prior to joining Thermo Fisher Scientific, Dr. Broyles was a consultant for over 25 years working with a large independent hospital network as pharmacy advisor chairman focused on developing and implementing hospital-wide clinical initiatives. Dr. Broyles has worked passionately throughout his career to define effective protocols and decision support processes in patient management and the use of diagnostic technology to help clinicians improve outcomes through better clinical care.

How many measles cases in 2025? Should you go to the hospital for measles? When did COVID start? How long can long COVID last? Why are microplastics bad? Covering the latest measles outbreak news, recent flu vaccine meeting updates, plus new studies on long COVID and the health effects of microplastics on the body with AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

States rush to ban food dyes ahead of federal action; NIH cuts funds for studies of vaccine hesitancy; RFK Jr. ridiculed for urging vitamin A for measles; Brain tumors in firefighters show signature of chemical exposure; Unpacking the causes of numbness, tingling and pain in lower extremities; Class-action lawsuit targets Depo-Provera as contributor to meningioma brain tumors; Uncovering the mystery of Trump's 20+ pound weight loss; Microplastics implicated in spiraling antibiotic resistance.

John Maytham speaks with Nazir Ismail, Head of Clinical Microbiology and Infectious Diseases at Wits University, about an extraordinary new discovery in the immune system that could revolutionize the fight against antibiotic-resistant infections. Scientists have found that the proteasome, previously known for recycling proteins, has an unexpected ability to produce bacteria-killing chemicals.See omnystudio.com/listener for privacy information.

Dr. Don and Professor Ben talk about the risks from kissing a raven. Dr. Don - risky ☣️ Professor Ben - risky ☣️ Ragnar raven in a lovely chatty and affectionate mood. | Raven Talking | TikTok Julie Andrews – My Favorite Things Lyrics | Genius Lyrics Elton John - Rocket Man (Official Music Video) - YouTube Salmonella ravens - Google Scholar Salmonella in Sheep in Iceland - PMC Prevalence, Characterization and Antibiotic Resistance of Salmonella Isolates in Large Corvid Species of Europe and North America Between 2010 and 2013 - Janecko - 2015 - Zoonoses and Public Health - Wiley Online Library Bacterial Diversity in Feces of Wild Bald Eagles, Turkey Vultures and Common Ravens from the Pacific Northwest Coast, U.S.A | bioRxiv Blue Oyster Cult - (Don't Fear) The Reaper (Lyrics) - YouTube

Antibiotic resistance is one of the greatest challenges of modern medicine, threatening the effectiveness of treatments and putting millions at risk. But what if the key to overcoming this crisis lies in nature itself? This month's episode of the Arqus Knowledge Pills podcast features Dr Agata Dorotkiewicz-Jach, a microbiologist at the University of Wrocław, who explores groundbreaking and sustainable antibacterial therapies.Dr Dorotkiewicz-Jach discusses alternative treatments such as bacteriophages, plant-based compounds, and anti-virulent therapies, highlighting their potential in fighting antibiotic-resistant bacteria. She also shares insights on the impact of climate change on antimicrobial resistance and the need for global cooperation.For the 37th episode of the Arqus Knowledge Pills, Agata explores how research and interdisciplinary approaches can help shape the future of medicine.Learn more about Dr Agata Dorotkiewicz-Jach:Dr Dorotkiewicz-Jach specializes in alternative antibacterial therapies at the University of Wrocław. She has led research on innovative treatment strategies and plays an active role in the Arqus Alliance, coordinating climate change and sustainability initiatives.

Howie and Harlan are joined by infectious disease specialist Michael Dunne to discuss the growing problem of antimicrobial resistance and what's needed to incentivize the development of new antibiotics. Harlan reflects on the controversy sparked by the release of his study on post-vaccination syndrome; Howie provides an update on the measles outbreak in Texas.  Links: Post-Vaccine Syndrome Harlan Krumholz: “Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination” “A small study on Covid vaccine safety sparks an online tempest” “Scientists Describe Rare Syndrome Following Covid Vaccinations” Antimicrobial Resistance and New Antibiotics "New bill would create a subscription payment model to jumpstart antibiotic development" Antimicrobials Working Group H.R.4127—DISARM Act of 2021 S.1355—PASTEUR Act of 2023 CDC: Antimicrobial Resistance Facts and Stats Michael Dunne: “Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales” Michael Dunne: “A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020" CDC: Core Elements of Antibiotic Stewardship "Crisis Looms in Antibiotics as Drug Makers Go Bankrupt" "Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate" Michael Dunne: “Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody” The Measles Outbreak “An unvaccinated child has died in the Texas measles outbreak” CDC: Measles, Mumps, Rubella (MMR) Vaccine Safety WHO: Measles "Consequences of Undervaccination—Measles Outbreak, New York City, 2018-2019" Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by infectious disease specialist Michael Dunne to discuss the growing problem of antimicrobial resistance and what's needed to incentivize the development of new antibiotics. Harlan reflects on the controversy sparked by the release of his study on post-vaccination syndrome; Howie provides an update on the measles outbreak in Texas.  Links: Post-Vaccine Syndrome Harlan Krumholz: “Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination” “A small study on Covid vaccine safety sparks an online tempest” “Scientists Describe Rare Syndrome Following Covid Vaccinations” Antimicrobial Resistance and New Antibiotics "New bill would create a subscription payment model to jumpstart antibiotic development" Antimicrobials Working Group H.R.4127—DISARM Act of 2021 S.1355—PASTEUR Act of 2023 CDC: Antimicrobial Resistance Facts and Stats Michael Dunne: “Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales” Michael Dunne: “A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020" CDC: Core Elements of Antibiotic Stewardship "Crisis Looms in Antibiotics as Drug Makers Go Bankrupt" "Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate" Michael Dunne: “Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody” The Measles Outbreak “An unvaccinated child has died in the Texas measles outbreak” CDC: Measles, Mumps, Rubella (MMR) Vaccine Safety WHO: Measles "Consequences of Undervaccination—Measles Outbreak, New York City, 2018-2019" Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Astronomy Daily - The Podcast: S04E44In this episode of Astronomy Daily, host Anna dives into a treasure trove of exciting developments in space exploration and astronomy. From NASA's New Horizons spacecraft nearing a historic milestone to groundbreaking advancements in gravitational wave detection, this episode is packed with insights that will spark your curiosity about the cosmos.Highlights:- New Horizons Approaches Termination Shock: Discover how NASA's New Horizons spacecraft is preparing to cross the termination shock, a crucial boundary that marks the transition from our solar system to interstellar space. This crossing, expected as early as 2027, could provide invaluable data about solar wind interactions and the outer heliosphere.- Breakthrough in Gravitational Wave Detection: Learn about a revolutionary advancement in adaptive optics that enhances the capabilities of gravitational wave observatories like LIGO. This technology could allow scientists to observe the universe's most dramatic events with unprecedented sensitivity, shedding light on black holes and the early universe.- Genomic Enumeration of Antibiotic Resistance in Space: Explore NASA's groundbreaking study aboard the International Space Station aimed at detecting antibiotic-resistant bacteria. This research not only safeguards astronaut health but also has significant implications for combating antibiotic resistance on Earth.- SpaceX Falcon 9 Rocket Debris Incident: Hear about the dramatic re-entry of debris from a SpaceX Falcon 9 rocket over Poland, creating a stunning light show. Fortunately, no injuries or damage were reported, but the incident highlights the complexities of space hardware re-entering Earth's atmosphere.- Firefly Aerospace's Blue Ghost Lunar Lander Update: Follow the progress of Blue Ghost as it successfully enters lunar orbit and prepares for a historic landing attempt. This mission represents a significant milestone in commercial space exploration and supports NASA's Artemis program goals.- New Tool in the Search for Extraterrestrial Life: Uncover how sulfur dioxide levels in planetary atmospheres could help identify potentially habitable worlds around red dwarf stars. This new method allows astronomers to narrow down their search for alien life by eliminating unlikely candidates.For more cosmic updates, visit our website at astronomydaily.io. Join our community on social media by searching for #AstroDailyPod on Facebook, X, YouTubeMusic, and TikTok. Don't forget to subscribe to the podcast on Apple Podcasts, Spotify, iHeartRadio, or wherever you get your podcasts.Thank you for tuning in. This is Anna signing off. Until next time, keep looking up and stay curious about the wonders of our universe.00:00 - Welcome back to Astronomy Daily01:05 - New Horizons and termination shock07:30 - Gravitational wave detection breakthrough12:15 - Antibiotic resistance study in space18:00 - Falcon 9 debris incident22:30 - Blue Ghost lunar lander update27:00 - Sulfur dioxide and extraterrestrial life32:00 - Conclusion and upcoming content✍️ Episode ReferencesNASA's New Horizons Mission[NASA TV Horizons](https://www.nasa.gov/newhorizons)Gravitational Wave Detection Technology[LIGO](https://www.ligo.caltech.edu)NASA's GEARS Experiment[NASA ISS](https://www.nasa.gov/iss)SpaceX Falcon 9 Information[SpaceX](https://www.spacex.com)Firefly Aerospace's Blue Ghost Mission[Firefly Aerospace](https://www.fireflyspace.com)Search for Extraterrestrial Life[Astrobiology](https://www.nasa.gov/astrobiology)Astronomy Daily[Astronomy Daily](http://www.astronomydaily.io)Become a supporter of this podcast: https://www.spreaker.com/podcast/astronomy-daily-space-news-discoveries--5648921/support.

In this episode of Tiny Show and Tell Us, we consider if bacteriophages could become our biggest allies in the fight against antibiotic resistance. Then we cover the historical role of "night soil men" and how some sewage treatment systems today are setting the standard for sustainable management of human excrement while also making sure we don't get sick. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.

Broadcast from KSQD, Santa Cruz on 2-06-2025: A live guest in the studio introduces Mom's Meals (momsmeals.com,) a program providing free meal delivery services for qualifying Medicare Advantage and Medi-Cal recipients with various dietary needs. During a lengthy live call, Dr. Dawn provides comprehensive guidance for a patient experiencing recurring COVID infections, discussing treatment options, long-haul symptoms, and recovery strategies. She announces FDA approval of Suzetrigine (Journavx), a novel non-opiate pain medication that works by blocking pain signals in the spinal cord, potentially marking a significant advancement in pain management. Responding to an email, Dr. Dawn provides detailed advice for treating a chronically splitting fingernail, recommending silk wrap treatment as a long-term solution. The show examines research showing omega-3 fatty acids, vitamin D, and exercise can slow biological aging, with participants aging 4 months slower over a 3-year study period. Dr. Dawn discusses concerning new research showing microplastics accumulating in mouse brains, kidneys and liver. She explores the emergence of valley fever (coccidiomycosis) as a climate change-related health threat, explaining how drones and genetic analysis are helping track its spread in California where 97% of cases originate The show explores promising research on oyster hemolymph proteins that may help combat antibiotic-resistant bacteria. A live caller follows up with a question about microplastic exposure from CPAP machines, with Dr. Dawn recommending inline bacterial paper-based filters to help capture microplastics and suggesting consultation with doctors about adjusting pressure settings to accommodate the filters.

Harmless bacteria that show antibiotic resistance and a tolerance to disinfection, have been isolated on the International Space Station.

Matters Microbial #71: Disinfecting the Built Environment December 25, 2024 Ever wonder what's growing on your toothbrush? Today, Dr. Erica Hartmann, Associate Professor of Civil and Environmental Engineering at Northwestern University, joins the #QualityQuorum to discuss how antimicrobial resistance can occur in the built environment we see all around us every day—and why it is vital to learn more about this association. Host: Mark O. Martin Guest: Erica Hartmann Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode An essay on the Hygiene Hypothesis. An overview of the “built environment.” The trouble with triclosan. An essay on heavy metal resistance. An article from Dr. Hartmann's group about the toothbrush microbiome (“Project Pottymouth”). A link to the Human Microbiome Project. An overview of antibiotic resistance and antibiotic resistance genes. An article about silver nanoparticles on toothbrushes. A blog post about probiotic cleaning products. An interesting post from Dr. Hartmann's team about viruses in your bathroom. A video by Dr. Hartmann about her research. Dr. Hartmann's faculty website. Dr. Hartmann's research team website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

In this week’s episode of "The Top Line," we bring you a special conversation from earlier this month at our New York City gala, where we celebrated this year’s Fierce 50 honorees. On stage, five extraordinary leaders shared their insights, experiences, and bold ideas shaping the future of healthcare and beyond. These honorees represent the five categories of this year’s Fierce 50: health equity, innovation, social impact, breakthroughs and patient advocacy. Each honoree brings powerful insights and inspiring stories to the table. From reimagining maternal healthcare and addressing antibiotic resistance to translating public health science, transforming healthcare with AI, and tackling rural health challenges, this panel highlights innovation and disruption at its finest. To learn more about the topics in this episode: Fierce 50 of 2024 Fierce 50 of 2024 - Innovation Honorees Fierce 50 of 2024 - Health Equity Honorees Fierce 50 of 2024 - Social Impact Honorees Fierce 50 of 2024 - Breakthroughs Honorees Fierce 50 of 2024 - Patient Advocacy Honorees See omnystudio.com/listener for privacy information.

Matters Microbial #70: Food Safety and Antibiotic Resistance December 18, 2024 Today, Dr. Dr. Erika Ganda, Assistant Professor of Food Animal Microbiomes in the Department of Animal Science at Pennsylvania State University, joins the #QualityQuorum to discuss the varied interests of her research team studying the intersection of animal husbandry, microbiome studies, and the threat of antimicrobial resistance. Host: Mark O. Martin Guest: Erika Ganda Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A video that Dr. Quinn and yours truly did for an event at Harvard University about #LuxArt. A video of a #LuxArt event I ran at ASMCUE a few years ago. An overview from the CDC about the One Health concept. The story of “Typhoid Mary.” An overview of rumen microbiology. The glass artwork of Jane Hartman. An article about Salmonella dublin and the impact on the dairy industry. An introduction to strategies of antibiotic resistance. A TED talk about the threat of antibiotic resistance. The concept of low level antibiotics to promote growth in chickens and other animals. A video demonstrating the swift rise of antibiotic resistance using  the MEGAPLATE approach. The accident in Brazil in 2015 releasing metal mining waste leading to increased antibiotic resistance. Evidence that microbial zinc resistance leads to increased antibiotic resistance. An explainer for proper antibiotic use. Dr. Ganda's faculty website. Dr. Ganda's research website Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

In this episode of Hart2Heart Dr. Mike Hart is joined by Dr. Sohail Gandhi to discuss the issue of the family physician shortage in the province. With 16,000 licensed family doctors but only 9,500 practicing comprehensive care, Dr. Gandhi sheds light on the reasons behind the shortage, including administrative burdens, compensation issues, and lack of respect from the government. Dr. Hart and Dr. Gandhi discuss potential solutions like improving working conditions and revisiting the healthcare system structure, including introducing deductibles and private healthcare to alleviate stress on the public system. They also dive into the role of other healthcare providers, the impact of policy decisions on patient care, and the pervasive issue of burnout among healthcare workers. Guest Bio and Links: Dr. Sohail Gandhi practices family medicine in Stayner, Ontario and has been the Investigating Coroner of Simcoe County since 2001. A graduate of the University of Toronto, Dr. Gandhi is currently an assistant clinical professor at Queen's University Medical School and a lecturer in medicine at the University of Toronto. He has held leadership positions at both the OMA and in the community, including Medical Staff Executive and Chief of Family Practice at Collingwood General and Marine Hospital, and Chair of the Board of the Georgian Bay Family Health Team. Listeners can learn more about Dr. Sohail Gandhi on his website and X @drmsgandhi  Show Notes: (0:00) Welcome back to the Hart2Heart Podcast with Dr. Mike Hart    (0:15) Dr. Hart introduces guest, Dr. Sohail Gandhi to the listeners (1:30) Today's topic: family physician shortage in Ontario  (3:00)  ”We've got 6,000 people already in Ontario who could do the job if we make, if we made the working conditions better.” (3:30) Misconceptions about the shortage (9:00) Solutions from other provinces (18:00) Role of pharmacists and nurse practitioners (21:30) Antibiotic resistance and healthcare challenges (28:00) Pharmacists in healthcare (30:30) Challenges in treating bladder infections (31:30) Coordinated care in Ontario (32:00) Primary care models and their effectiveness (36:30) Patient accountability in healthcare (39:30) Obesity and public health (45:30 Benefits of the Denmark healthcare system (49:00) Private vs. public healthcare systems (54:30) Burnout in the medical profession (58:00) Closing thoughts  --- Dr. Mike Hart is a Cannabis Physician and Lifestyle Strategist. In April 2014, Dr. Hart became the first physician in London, Ontario to open a cannabis clinic. While Dr. Hart continues to treat patients at his clinic, his primary focus has shifted to correcting the medical cannabis educational gap that exists in the medical community.  Connect on social with Dr. Mike Hart: Social Links: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##New FDA Approval for Cancer TreatmentThe FDA has recently approved a new drug for the treatment of advanced ovarian cancer. This drug has shown promising results in clinical trials, with patients experiencing longer survival rates and fewer side effects compared to traditional treatments. This approval is a significant advancement in the field of oncology and offers hope to patients who are battling this difficult disease.##Breakthrough in Alzheimer's ResearchResearchers have made a breakthrough in the field of Alzheimer's research, identifying a potential new target for treatment. By targeting this specific protein, scientists believe they may be able to slow or even reverse the progression of the disease. This discovery is a major step forward in the fight against Alzheimer's and could potentially change the lives of millions of people worldwide.##Positive Results in COVID-19 Vaccine TrialA leading pharmaceutical company has announced positive results in a phase 3 clinical trial for their COVID-19 vaccine. The vaccine has shown to be highly effective in preventing infection and has been well-tolerated by patients. This news brings hope to many as the world continues to battle the ongoing pandemic, and could potentially lead to widespread vaccination efforts in the near future.##FDA Issues Warning on Popular Diabetes MedicationThe FDA has issued a warning on a popular diabetes medication, citing potential safety concerns. Patients who are currently taking this medication are advised to speak with their healthcare provider about alternative treatment options. This warning serves as a reminder of the importance of monitoring drug safety and efficacy, and highlights the FDA's commitment to protecting public health.##Growing Concerns Over Antibiotic ResistanceHealth officials are increasingly concerned about the rise of antibiotic resistance, which poses a serious threat to public health. Overuse and misuse of antibiotics have led to the development of resistant strains of bacteria, making infections more difficult to treat. It is crucial that healthcare providers and patients alike take steps to combat this growing issue, such as practicing proper antibiotic stewardship and infection control measures.##Innovations in Gene TherapyAdvancements in gene therapy have paved the way for new treatment options for a variety of genetic disorders. By targeting specific genes, scientists are able to correct genetic mutations that cause disease, offering hope to patients who previously had limited treatment options. These innovations have the potential to revolutionize healthcare and improve outcomes for individuals living with genetic conditions.##Rise in Telemedicine UsageThe COVID-19 pandemic has led to a significant rise in telemedicine usage, as patients seek alternative ways to receive medical care while minimizing potential exposure to the virus. Telemedicine offers a convenient and accessible option for patients to consult with healthcare providers, leading to improved access to care and increased patient satisfaction. This trend is likely to continue even after the pandemic subsides, shaping the future of healthcare delivery.##Investments in Biotech StartupsInvestors are increasingly turning their attention towards biotech startups, recognizing the potential for innovation and growth in this sector. These startups are developing cutting-edge technologies and treatments that have the potential to revolutionize healthcare. The influx of investment capital is fueling research and development efforts, bringing new therapies to market at an accelerated pace. This trend highlights the importance of supporting early-stage biotech companies in driving progress within the industry.##

Welcome to Med Tech Gurus! In today's exciting episode, we are joined by Alan D. Roth, the Chief Executive at Oxford Drug Design. Alan and his team are at the forefront of leveraging artificial intelligence to revolutionize drug discovery, addressing some of the most pressing healthcare challenges, including antibiotic resistance and cancer treatment. With deep expertise in computational chemistry, Oxford Drug Design has successfully built a platform that accelerates drug development by predicting, designing, and optimizing molecules that can be produced at scale and perform effectively in real-world clinical settings. In this conversation, Alan shares the key innovations driving their Synth AI platform, which goes beyond theory to deliver viable drug candidates. We'll explore how Oxford Drug Design's platform not only identifies potent molecules but also ensures they can be manufactured cost-effectively and with clean safety profiles. Alan also discusses the importance of fostering innovation, balancing focus with creativity, and raising capital in the life sciences space. This episode provides a fascinating deep dive into AI's impact on drug discovery and offers invaluable advice for entrepreneurs looking to navigate the complex world of healthcare technology. Get ready for an insightful and inspiring discussion about the future of AI in healthcare with Alan Roth—this is one you don't want to miss!

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

The infections disease landscape is constantly changing - challenging our standard treatments. Can new - as well as ancient - therapies be the answer? Hear from experts on the cutting edge of phage therapy, HIV/AIDS research and cancer care about what is on the horizon to improve human health. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39982]

Send us a textChildren under five years old are fragile. They're more vulnerable than adults to malaria, pneumonia, diarrhea, and other infections. A growing number of these infections that sicken and kill children are resistant to the drugs developed to treat them – a phenomenon known as antimicrobial resistance, or AMR.AMR is a big killer. Nearly five million deaths are caused in part by drug-resistant infections each year. While the percentage of children killed by these infections has fallen greatly since 1990, hundreds of thousands still die. Vaccines can help.  So can infection control measures as simple as handwashing routines. Patients everywhere also need to be able to get the best antibiotics to treat their infections at the right time. These infections are often more difficult to treat in low- and middle-income countries in part because they have fewer staff to clean and to care for patients, less access to effective antibiotics, and crowded neonatal units, which can worsen the spread of germs. In a special edition of One World, One Health recorded for AMR Awareness Week, we spoke with Dr. Heather Finlayson, a Pediatric Infectious Diseases Specialist at Stellenbosch University's Tygerberg Hospital in Cape Town, South Africa.Listen as she tells us about her struggles fighting drug-resistant superbugs in the youngest of children.

Are antibiotics negatively impacting our health? Tune in for an inspiring discussion with Dr. Brian Huber on The Silent Crisis of Antibiotic Resistance for Diabetic Patients.Moments with Marianne airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio affiliate!  Dr. Brian J. Huber, D.V.M., A.B.V.P., is the founder and CEO of Advanced Performance Technology, an Indiana and Texas-based company that has created novel over-the-counter medications to treat wounds, resistant bacterial and fungal infections, and other conditions. Dr. Huber has over 30 years of experience working in the human medical and veterinary arenas.  http://www.aptdeliverysystem.comFor more show information visit: www.MariannePestana.com#healing #healingjourney #diabetic #antibioticresistance #DrBrianHuber #woundcare #healthcare #health #wellbeing #wellness #medical #medicine #APT #APTT3X

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as they discuss the urgency of tackling antimicrobial resistance and the coordinated global efforts needed to save the struggling market of antibiotics.  Extended Release is an Off Script series to revisit conversations with our sources and explore new developments, gain deeper insights, and provide updates on the impact of their work. 

It's always interesting to think about how many technologies that we take for granted today, such as genome sequencing and bioengineering, were completely unheard of just a few decades ago. This episode, we're going back to the roots of these applications with Dr. James Collins, who is widely regarded as one of the founders of the field of synthetic biology. Tune in to hear his thoughts on the importance of leveraging the tools we have today for pandemic prevention and readiness, how to reframe thinking around biosecurity when it comes to applications of these technologies, and how AI can help us outrun antibiotic resistance with rapid drug discovery.Dr. James Collins is a professor of medical engineering and science at MIT, a core faculty member at the Wyss Institute of Harvard University, and a member of the Broad Institute of MIT and Harvard. He is a member of the National Academies of Engineering, Science, and Medicine, and his technologies have been licensed by over 25 biotech and medical device companies.

एंटीबायोटिक की खोज मानव जाति के लिए एक महत्वपूर्ण क्षण था। इससे इंसानों का जीवनकाल बढ़ा और स्वास्थ्य सेवा में क्रांतिकारी बदलाव आया क्योंकि लोग अब मामूली चोटों और संक्रमणों के कारण नहीं मर रहे थे। लेकिन अब एक नया खतरा मंडरा रहा है - सुपरबग बैक्टीरिया अब तक खोजे गए एंटीबायोटिक्स के प्रति तेजी से प्रतिरोधी होते जा रहे हैं। एंटीबायोटिक प्रतिरोध को तेजी से बढ़ाने वाले कारण क्या हैं? इस छिपी हुई महामारी को रोकने के लिए क्या किया जा सकता है? माइक्रोबायोलॉजिस्ट और ‘व्हेन द ड्रग्स डोंट वर्क' के लेखक अनिर्बान महापात्रा इस विषय को सरल बनाने और एंटीबायोटिक्स के उपयोग और दुरुपयोग से जुड़े कई मिथकों को तोड़ने के लिए हमारे साथ इस पुलियाबाज़ी पर जुड़ें। आप भी गौर से सुनिए और अगर बातें काम की लगें तो अपने परिवारजनों के साथ साझा करें। The discovery of antibiotics was a pivotal moment for humankind. Lifespan increased and healthcare was revolutionized as people were no longer dying due to minor injuries and infections. But now, there is a real danger of losing the evolutionary arms race with superbug bacterias, who are increasingly becoming resistant to the antibiotics we have discovered so far. What are the causes that's fast tracking antibiotic resistance? What can be done to arrest this hidden pandemic? What should policymakers do? Anirban Mahapatra, microbiologist and author of ‘When The Drugs Don't Work', joins us to simplify this topic and bust the many myths that surround the use and misuse of antibiotics.  We discuss:* What are superbugs?* Bacterias are everywhere* Overuse of antibiotics* How does antibiotic resistance develop?* Horizontal Gene Transfer* Moore's law vs Eroom's law* Myths about antibiotics use* Antibiotics in agriculture and poultry farming* What should be the policy response?* Market failure in drug discoveryReadings:When The Drugs Don't Work: The Hidden Pandemic that Could End Modern Medicine by Anirban Mahapatrahttps://www.animahapatra.com/Related Puliyabaazi:मानसिक आरोग्य और हम. Importance of Mental Health.प्रयोगशास्त्र : रैण्डमाइस्ड कंट्रोल ट्रायल की कहानी. Understanding RCTs.If you have any questions for the guest or feedback for us, please comment here or write to us at puliyabaazi@gmail.com. If you like our work, please subscribe and share this Puliyabaazi with your friends, family and colleagues.Website: https://puliyabaazi.inGuest: @bhalomanushHosts: @saurabhchandra @pranaykotas @thescribblebeeTwitter: @puliyabaazi Instagram: https://www.instagram.com/puliyabaazi/Subscribe & listen to the podcast on iTunes, Google Podcasts, Castbox, AudioBoom, YouTube, Spotify or any other podcast app. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.puliyabaazi.in

In this episode of Keeping It Real, Jillian dives into the alarming rise of antibiotic-resistant bacteria and the profound dangers they pose to global health. From the overprescription of antibiotics in humans to their rampant use in factory farming, she explores how these practices are fueling the growth of "superbugs" that traditional medicines can no longer defeat. Jillian also discusses a few key strategies to combat this looming crisis, including responsible antibiotic use, sustainable farming practices, and the power of voting with our dollars. Join her for this hot take about how we can prevent a future where life-saving drugs no longer work.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Broadcast from KSQD, Santa Cruz on 10-03-2024: In response to several listener emails, Dr. Dawn expands on the benefits of Nori powder and Rhamnan sulfate, including their effects on cholesterol and the glycocalyx. TheThe type of Nori seaweed species with the high amounts of Rhamnam sulfate is monostroma nitidum (Japanese name Hitoegusa,) and can be obtained online at Https://okume.us. She then took a little time to recap the antiviral, anti-glycemic, and cardiovascular benefits of Rhamnan sulfate found in certain seaweeds. The doctor then emphasized the importance of hot water extraction for seaweed and mushrooms as dried powders to increase bioavailability of beneficial compounds. In response to another email, Dr. Dawn addressed green tea's interaction with iron which binds and prevents absorption and its potential impact on EGCG's antioxidant properties. This lead to a brief reassuring discussion about internet memes around the safety of tea consumption and debunking concerns about lead contamination in most commercial teas. We then heard about the potential link between a common artificial fragrance Musk Ambrette, which is implicated in causing early puberty in girls as young as 9 years old. Dr. Dawn briefly comments on the need for a new economic model to address the growing threat of antibiotic-resistant superbugs and the need for new antibiotics. A discussion on so-called anti-nutrients in foods, including lectins, oxalates, and phytates, and their actual impact on health. The importance of cooking methods in reducinganti-nutrients and increasing mineral availability in foods. The potential benefits of phytoestrogens, particularly from soy, in reducing cancer risk for young women. The risks associated with processed and convenience foods, particularly regarding microplastics. In response to a telephone question, the doctor gave some strategies for managing herpes outbreaks and its potential long-term effects on brain health. She also emphasized the importance of sleep and exercise for longevity and overall health.

How can phages, the viruses of bacteria, be used to reduce agrichemical and antibiotic use? Dr Heather Hendrickson explains.

Liz and Becca break down the widespread misuse and overuse of antibiotics and its long-term impact on your health. They explore how antibiotics, while life-saving in certain cases, can damage the gut microbiome, lead to antibiotic resistance, and contribute to chronic health issues. Learn how to protect your body if you need antibiotics and discover natural alternatives that can help you avoid their harmful effects. This episode is a must-listen for anyone concerned about their gut health and overall well-being.***

Professor Ian Henderson has spent his career searching for new treatments in the fight against antibiotic resistance superbugs

Rosemary Bartel had no idea her life was going to take a turn when she went to a hospital near her home in Chilton, Wisconsin in the United States for standard knee replacement surgery – her second such operation. She was ready to work hard to recover and return to her busy job at her Roman Catholic diocese. But Rosie developed an all-too-common infection known as MRSA—methicillin-resistant Staphylococcus aureus. It's one of the best-known examples of antimicrobial-resistant microbes, often called superbugs. The United Nations is devoting a high-level meeting to the problem in September 2024 in the hopes of getting nations to do more to fight antimicrobial resistance or AMR.Now, 15 years later, Rosie has had her leg and hip amputated because the infection got into her bones. She has suffered numerous other infections, been in comas, lost her job, lost her health insurance, and lost most of the life she had loved.“I will probably be paying hospital bills for the rest of my life,” Rosie tells One World, One Health. Rosie is one of the luckier victims of AMR. She's still alive. Five million people a year die from complications caused by these drug-resistant germs. Now, Rosie shares her story as widely as she can as part of the Patient Family Partners Network, a group of patient advocates working to improve healthcare in the United States, and the Leapfrog Group, a nonprofit patient safety advocacy organization. She's also written a book, “Rosie's Story,” about her experience with this devastating and unending infection. Listen as Rosie describes what happened to her and what she hopes to do to help stop it from happening to others

Dr Dean St Mart joins Coaches Skip Hill & Scott McNally TIME STAMPS BELOW BSG Coaching QA Podcast 265

This week, Faith talks to Dr. Daniel Freedberg, a gastroenterologist at NewYork-Presbyterian and Columbia. They discuss how the gut microbiome contributes to our overall health, and what we can do to keep the microbes in our gut thriving. Along the way, Dr. Freedberg demystifies probiotics, explains the biggest threat to our gut microbes, and explains why fiber is the most powerful tool for supporting microbial diversity in our digestive system.

Join Liz and Becca as they answer listener questions about the hidden complexities of H. pylori and gut health. Discover why conventional antibiotic treatments often fail and uncover the secrets to truly eradicating this stubborn bacteria. Learn about the critical role of biofilms, antibiotic resistance, and the importance of proper stomach acid levels. If you're struggling with persistent digestive issues like bloating, heartburn, or fatigue even after treatment, this episode is a must-listen. Tune in to get practical tips and expert insights on achieving optimal gut health and boosting your immune system. Don't miss out on this eye-opening discussion!***

What if I told you that a single biochemical process could be the key to unlocking your body's full potential? In this eye-opening episode of The Dr. Josh Axe Show, we dive deep into the world of methylation - a crucial process affecting over 40% of Americans. Dr. Axe breaks down this complex topic, revealing how it impacts everything from your mood to your ability to detoxify. Tune in to discover: The 'sticky note' analogy that makes understanding methylation a breeze Why poor methylation could be behind your unexplained fatigue, brain fog, or mood swings The shocking connection between methylation and your risk of heart disease and autoimmune disorders Nature's top methylation boosters - including one surprising food that outperforms all others How your gut health might be the secret key to optimizing your methylation pathway The MTHFR gene variant: what it means and why you should care Simple, actionable steps to support your body's methylation process starting today Whether you're a health enthusiast or struggling with unexplained symptoms, this episode is a must-listen. Dr. Axe delivers complex information in an easy-to-understand format, equipping you with the knowledge to take control of your health. By the end of this show, you'll have a clear understanding of methylation and a practical toolkit to optimize this vital process in your body. Don't miss out on this game-changing information - your cells will thank you! Want more of The Dr. Josh Axe Show? Subscribe to the YouTube channel. Follow Dr. Josh Axe Instagram Twitter Facebook Tik-Tok ------  Links:  Ferira, L. (2021). "The Role of Methylation in Human Health." Journal of Nutrition. Rountree, R. (2020). "Environmental Impacts on Methylation." Environmental Health Perspectives. Masterjohn, C. (2022). "Riboflavin and Its Importance for Methylation." Nutritional Biochemistry. CDC (2023). "Antibiotic Resistance and Usage Statistics." WHO (2022). "COVID-19 and Antibiotic Usage." Smith, A. D., & Refsum, H. (2016). "Homocysteine, B Vitamins, and Cognitive Impairment." Annual Review of Nutrition. Watanabe, F., & Yabuta, Y. (2013). "Vitamin B12 Sources and Bioavailability." Food and Nutrition Bulletin. Bailey, L. B., & Gregory, J. F. (2011). "Folate and Other Methyl Donors: Effects on the Risk of Cardiovascular Disease." Current Opinion in Lipidology. Pinna, K. L. (2018). "Probiotics and Gut Health: Mechanisms and Applications." Frontiers in Microbiology. Ulta Labs. (2023). "MTHFR Gene Variation Testing and Homocysteine Testing."

The looming danger of antibiotic resistance may have fallen out of the public consciousness but is still very much in the mind of those in public healthcare and research. As promising new research is published, the University of Birmingham's Laura Piddock and GP Margaret McCartney get to the bottom of why antibiotic resistance is still so difficult to tackle. Marine biologist Helen Scales joins us in the studio to talk about her new book “What the Wild Sea Could Be” which uses changes in the Earth's past to predict what we can expect to happen to our oceans in the coming years. Cosmologist Andrew Pontzen speculates on what happens in and around the extreme environment of a black hole as news of the first observations of the “plunging zone” comes to light. And as the EU head to ban smoky flavoured crisps we ask what the science behind this decision is with Food scientist Stuart Farrimond. Presenter: Marnie Chesterton Producers: Ella Hubber and Hannah Robins Researcher: Caitlin Kennedy Editor: Martin Smith Production Co-ordinator: Jana Bennett-Holesworth

   Join us on War Docs as we welcome Army Physician MAJ Mary Ford, an infectious disease specialist and lead author of the acclaimed Military Medicine Journal's article of the year: Clinical Characteristics and Resistance Patterns of Pseudomonas aeruginosa Isolated From Combat Casualties https://pubmed.ncbi.nlm.nih.gov/34196358/    Listen in as MAJ Ford shares the impactful findings of her team's research on Pseudomonas aeruginosa in combat casualties, a topic of paramount importance to military health. Her personal journey into the infectious disease field, spurred by early curiosities and familial influences, and the progression of her military career make for a captivating story of dedication and passion.       In this engaging conversation, we also tackle the critical subject of infection prevention and antimicrobial stewardship in the face of combat trauma. Hear about the vital role of simple measures, like hand hygiene, in combating infections, especially those caused by the antibiotic-resistant Pseudomonas aeruginosa. Discover how MAJ Ford's team utilized the Trauma Infectious Disease Outcomes Study to uncover that approximately 6% of combat trauma patients developed Pseudomonas infections. The implications of these findings are vast, offering significant advancements for clinical outcomes and infection control in military medical settings. Tune in for a deep understanding of how such research continues to shape practices and policies within the Department of Defense.   Chapters: (00:02) Infectious Disease in the Military (07:12) Combat Trauma Infections and Pseudomonas   Chapter Summaries: (00:02) Infectious Disease in the Military  MAJ Mary Ford's research on Pseudomonas aeruginosa in combat casualties and its impact on military health, her personal journey into infectious disease, and the enduring need for ongoing research in the Department of Defense.   (07:12) Combat Trauma Infections and Pseudomonas   Infection prevention and antimicrobial stewardship are crucial in controlling Pseudomonas infections in combat trauma patients.   Take Home Messages: In the context of military medicine, the issue of infections following combat trauma is a significant concern, with Pseudomonas aeruginosa identified as a noteworthy pathogen due to its prevalence in prolonged hospital stays and its intrinsic antibiotic resistance mechanisms. Infection prevention and antimicrobial stewardship are critical components in the management of combat trauma infections. Basic practices such as hand hygiene play a pivotal role in controlling the spread of infections and can have substantial impacts on patient outcomes. Research conducted through the Trauma Infectious Disease Outcomes Study (T-DOS) has revealed that about 6% of combat trauma patients develop Pseudomonas infections, which underscores the importance of understanding and addressing these infections to improve clinical practices and infection control protocols. Combat trauma patients with Pseudomonas infections often experience lengthy hospital stays and intensive care unit admissions, highlighting the need for robust infection prevention strategies in military healthcare settings to reduce the burden of these nosocomial infections. The fight against infections like Pseudomonas aeruginosa in military medicine is an ongoing challenge that requires continuous research and evidence-based practices to ensure the health and readiness of military personnel. Basic infection control measures remain foundational in mitigating infectious threats.   Episode Keywords:  Military Medicine, Infectious Disease, Pseudomonas aeruginosa, Combat Trauma, Antimicrobial Stewardship, Research, Clinical Practices, Infection Control, Military Health, Nosocomial Pathogen, Antibiotic Resistance, Retrospective Analysis, Prospectively Collected Data, Trauma Infectious Disease Outcomes Study, Clinical Outcomes, Infection Prevention, Military Medical Environments Hashtags: #wardocs #military #medicine #podcast #MilMed #MedEd #MilitaryMedicine, #PseudomonasAeruginosa, #CombatInfections, #InfectiousDiseases, #AntimicrobialStewardship, #WarDocsPodcast, #MilitaryHealthcare, #TraumaInfections, #InfectionPrevention, #ClinicalResearch   Honoring the Legacy and Preserving the History of Military Medicine   The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast   Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you.   WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield, demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast  

Anyone who has had a urinary tract infection knows how agonising they can be. Some infections go away on their own, but many need antibiotics. Beneath the surface of this very common infection lie many mysteries, unanswered questions, and unnecessary suffering. And it gets to the heart of the challenge of tackling antimicrobial resistance. Madeleine Finlay speaks to Dr Jennifer Rohn, head of the centre for urological biology at University College London, about what we now understand about how UTIs take hold, and the complexity surrounding their treatment. Help support our independent journalism at theguardian.com/sciencepod

Episode Highlights With Dr. Elisa SongThe state of children's health today, and why we are seeing some type of problemAlarming data about the rise of autoimmune disorders in children Why teenagers are at the highest risk and the most rapidly rising segment of the population for autoimmunityWhat to know about antibiotic use The time and place for antibiotics and what to do if kids need themWhen antibiotics can be avoided and what to try insteadAntibiotics are the single biggest disrupter of the gut microbiome Some experts think that antibiotic resistance will be a leading cause of death by 2050As much as 70% of antibiotic prescriptions may be unnecessary Ways to recover from antibiotic useSix questions to ask if your child is prescribed an antibioticTips for beating ear infections in kids without antibiotics What to do when your child runs a fever and debunking some fever mythsTips that work for cold and flu in kids including a well-studied herbal remedyResources We MentionHealthy Kids, Happy Kids: An Integrative Pediatrician's Guide to Whole Child Resilience by Elisa Song, MDGet Your Child Through Flu Season NaturallyHealthy Kids Happy KidsEar OiliMOM PodcastIf you need a mom friend right now, you've come to the right place.Listen on: Apple Podcasts Spotify

How Election Science Can Support DemocracyThis week, the election season shifted into full gear with the Super Tuesday slate of primaries. But as the ballot options become more cemented, it's not just pollsters and campaign operatives who are preparing for the elections—scientists are too.The Union of Concerned Scientists has established what it calls an election science task force, looking at everything from ballot design to disinformation to voting security. Dr. Jennifer Jones, program director for the Center for Science and Democracy at the Union of Concerned Scientists, joins Ira to describe the goals of the effort in the weeks and months ahead.The Genetic Roots Of Antibiotic ResistanceAntibiotic resistance—when pathogens no longer respond to the conventional antibiotic medications—is a serious medical problem. According to the CDC, over 2.8 million antibiotic-resistant infections occur in the U.S. each year, causing some 35,000 deaths. It's in part due to overprescription of antibiotics in medicine, and the widespread use of antibiotics in animal agriculture. But the problem isn't entirely of humans' making. The roots of antibiotic resistance go back millions of years.A recent study in the Proceedings of the National Academy of Sciences collected hundreds of soil and poop samples from around the world, to try to trace back the genetics of how resistance arose in Enterococcus, a genus of bacteria that live in the guts of pretty much every land animal. In the course of their analysis, the researchers identified 18 entirely new species in the genus Enterococcus, with over 1,000 genes that had never been seen before.Dr. Michael Gilmore, the Chief Scientific Officer at Mass Eye and Ear, joins Ira to talk about the study and what the team hopes to learn about the causes of antibiotic resistance.Transcripts for each segment will be available the week after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.